Beta Bionics, Inc. (BBNX) Operating Leases (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Operating Leases data on file, last reported at $5.1 million in Q1 2026.

• Quarterly Operating Leases fell 6.92% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 6.92% YoY) and the FY2025 annual result came in at $5.4 million, down 6.3% from the prior year.
• Operating Leases eased to $5.1 million in Q1 2026 per BBNX's latest filing, from $5.4 million in the prior quarter.
• The five-year high for Operating Leases was $5.7 million in Q4 2024, with the low at $3.0 million in Q4 2023.
• Average Operating Leases over 4 years is $5.1 million, with a median of $5.4 million recorded in 2025.
• Year-over-year, Operating Leases surged 90.93% in 2024 and slipped 6.92% in 2026.
• Beta Bionics' Operating Leases stood at $3.0 million in 2023, then surged by 90.93% to $5.7 million in 2024, then declined by 6.3% to $5.4 million in 2025, then retreated by 5.44% to $5.1 million in 2026.
• Business Quant data shows BBNX's Operating Leases at $5.1 million in Q1 2026, $5.4 million in Q4 2025, and $5.7 million in Q3 2025.